Reporter PET Images Bortezomib Treatment-Mediated Suppression of Cancer Cell Proteasome Activity-Reference-Cited by-同舟云学术

Reporter PET Images Bortezomib Treatment-Mediated Suppression of Cancer Cell Proteasome Activity

Published:2018-08-16 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lee Jin Hee,Jung Kyung-Ho,Quach Cung Hoa Thien,Park Jin Won,Moon Seung Hwan,Cho Young Seok,Lee Kyung-Han

Funder

National Research Foundation of Korea (NRF)

Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (#NRF-2012R1A1A2041354 and #NRF-2015R1A2A2A01006419)

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-29642-w.pdf

Reference26 articles.

1. Dobbelstein, M. & Moll, U. Targeting tumour-supportive cellular machineries in anticancer drug development. Nat Rev Drug Discov 13, 179–196, https://doi.org/10.1038/nrd4201 (2014).

2. Bedford, L., Lowe, J., Dick, L. R., Mayer, R. J. & Brownell, J. E. Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov 10, 29–46, https://doi.org/10.1038/nrd3321 (2011).

3. Ciechanover, A. The ubiquitin-proteasome proteolytic pathway. Cell 79, 13–21 (1994).

4. Loda, M. et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 3, 231–234 (1997).

5. Oren, M. & Kotler, E. p53 mutations promote proteasomal activity. Nat Cell Biol 18, 833–835, https://doi.org/10.1038/ncb3392 (2016).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatiotemporal quantitative microRNA-155 imaging reports immune-mediated changes in a triple-negative breast cancer model;Frontiers in Immunology;2023-06-08

2. Targeting poor proteasomal function with radioiodine eliminates CT26 colon cancer stem cells resistant to bortezomib therapy;Scientific Reports;2020-08-31

3. Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents;Frontiers in Chemistry;2020-06-30